Literature DB >> 21035442

Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients.

Sabrina Bauer1, Josef Wanninger, Markus Neumeier, Sylvia Wurm, Johanna Weigert, Andrea Kopp, Margarita Bala, Andreas Schäffler, Charalampos Aslanidis, Christa Buechler.   

Abstract

Type 2 diabetes (T2D) is characterized by increased oxidative stress contributing to the development of cardiovascular disease (CVD). Monocytes are critically important in the pathogenesis of CVD and antioxidant enzymes like superoxide dismutase (SOD2) protect these cells from excessive reactive oxygen species (ROS). Adiponectin is an adipocyte-derived protein with atheroprotective function and the effect of adiponectin on monocyte SOD2 was analyzed herein. Adiponectin upregulated SOD2 mRNA and dose- and time-dependently induced SOD2 protein in primary human monocytes. Elevated systemic free fatty acids (FFA) are commonly found in T2D patients and palmitic acid as well as oleic acid reduced monocyte SOD2 protein. Adiponectin mediated upregulation of SOD2, however, was not affected by FFA incubation. SOD2 protein was reduced in T2D monocytes compared to monocytes of age- and body mass index-matched healthy controls. Adiponectin still induced SOD2 in T2D monocytes but efficiency tended to be reduced. In summary this study indicates that elevated systemic free fatty acids and impaired adiponectin activity contribute to reduced SOD2 and most likely increased oxidative stress in T2D monocytes. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035442     DOI: 10.1016/j.yexmp.2010.10.010

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  7 in total

1.  Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease.

Authors:  Cosmina Ioana Bondor; Alina Ramona Potra; Diana Moldovan; Crina Claudia Rusu; Mariana Ciorba Pop; Adriana Muresan; Dan Stefan Vladutiu; Ina Maria Kacso
Journal:  Int Urol Nephrol       Date:  2015-05-14       Impact factor: 2.370

2.  Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet.

Authors:  Adriano M de Assis; Anderson Rech; Aline Longoni; Liane N Rotta; Cristiane C Denardin; Matheus A Pasquali; Diogo O Souza; Marcos L S Perry; José C Moreira
Journal:  Mol Cell Biochem       Date:  2011-10-12       Impact factor: 3.396

3.  Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.

Authors:  Josef Wanninger; Sabrina Bauer; Kristina Eisinger; Thomas S Weiss; Roland Walter; Claus Hellerbrand; Andreas Schäffler; Akiko Higuchi; Kenneth Walsh; Christa Buechler
Journal:  Mol Cell Endocrinol       Date:  2011-11-18       Impact factor: 4.102

4.  Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.

Authors:  Young-Eun Cho; Aninda Basu; Anzhi Dai; Michael Heldak; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-28       Impact factor: 4.249

Review 5.  Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism.

Authors:  Rikke K J Olsen; Nanna Cornelius; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2015-05-30       Impact factor: 4.982

6.  Adiponectin gene therapy prevents islet loss after transplantation.

Authors:  Chengshi Wang; Xiaojiong Du; Fudong Fu; Xiaoyu Li; Zhenghao Wang; Ye Zhou; Liping Gou; Wei Li; Juan Li; Jiayi Zhang; Guangneng Liao; Lan Li; Yuan-Ping Han; Nanwei Tong; Jingping Liu; Younan Chen; Jingqiu Cheng; Qi Cao; Erwin Ilegems; Yanrong Lu; Xiaofeng Zheng; Per-Olof Berggren
Journal:  J Cell Mol Med       Date:  2022-08-17       Impact factor: 5.295

7.  Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes.

Authors:  David W Freeman; Nicole Noren Hooten; Erez Eitan; Jamal Green; Nicolle A Mode; Monica Bodogai; Yongqing Zhang; Elin Lehrmann; Alan B Zonderman; Arya Biragyn; Josephine Egan; Kevin G Becker; Mark P Mattson; Ngozi Ejiogu; Michele K Evans
Journal:  Diabetes       Date:  2018-05-02       Impact factor: 9.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.